Skip to main content

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Genetic basis of scleroderma.

With this study we aim at studying the genetic background of the disease to deepen in its pathogenesis to be able to establish links between genetic variations and different clinic-biologic patterns. This research is based on a multicentric study and it is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute to it by sending samples from our cohort of patients along with the clinical data.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Spanish Registry of Scleroderma patients (Systemic Autoimmune Diseases Group, Spanish Internal Medicine Association).

This multicentric study includes 14 hospitals with a cohort of 916 scleroderma patients. Its main goal consists in determining both the prognosis factors and the survival of these patients.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Projects

ESTUDIO DE NUEVOS ANTIGENOS EN ESCLERODERMIA

IP: Carmen Pilar Simeón i Aznar
Collaborators: Vicenç Fonollosa Pla, Alfredo Guillen Del Castillo
Funding agency: Instituto de Salud Carlos III
Funding: 78650
Reference: PI16/02088
Duration: 01/01/2017 - 30/06/2021

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

IP: Carmen Pilar Simeón i Aznar
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: PDJF-2012-01
Duration: 01/01/2013 - 31/12/2013

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Génesis Martín Fernández

Génesis Martín Fernández

Research technician
Read more
Anna Maria Cueto Gonzalez

Anna Maria Cueto Gonzalez

Main researcher
Genetics Medicine
Read more
Iratxe Ugarriza Serrano

Iratxe Ugarriza Serrano

Neurovascular Diseases
Read more
Josefa Mª Heredia Montiel

Josefa Mª Heredia Montiel

Administration and Management
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.